Annual report pursuant to Section 13 and 15(d)

Note 13 - Stock-based Compensation

v3.24.1
Note 13 - Stock-based Compensation
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

13. Stock-Based Compensation

 

Equity Incentive Plans – The Company’s 2013 Equity Compensation Plan (the “2013 Plan”) was adopted for the purpose of providing equity incentives to employees, officers, directors and consultants including options, restricted stock, restricted stock units, stock appreciation rights, other equity awards, annual incentive awards and dividend equivalents. Through a series of amendments to the 2013 Plan, the total number of authorized shares available for issuance of common stock under the Plan was 750,000 shares.

 

On April 11, 2023, the Board of Directors adopted a new equity incentive plan, the Professional Diversity Network, Inc. 2023 Equity Compensation Plan (the “2023 Equity Compensation Plan”). The 2023 Equity Compensation Plan was approved by the Company’s stockholders on June 15, 2023. The 2023 Equity Compensation Plan supersedes and replaces the 2013 Plan, and no new awards will be granted under the 2013 Plan. Any awards outstanding under the 2013 Plan remain subject to and will be paid under the 2013 Plan. The 2023 Equity Compensation Plan reserves 750,000 shares of common stock for issuance of awards to directors, officers, employees and qualifying consultants of the Company and its affiliates.

 

 

Stock Options

 

The fair value of options is estimated on the date of grant using the Black-Scholes option pricing model. The valuation determined by the Black-Scholes pricing model is affected by the Company’s stock price, as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. The risk-free rate is based on the U.S. Treasury rate for the expected life at the time of grant, volatility is based on the average long-term implied volatilities of peer companies, the expected life is based on the estimated average of the life of options using the simplified method, and forfeitures are estimated on the date of grant based on certain historical data. The Company utilizes the simplified method to determine the expected life of its options due to insufficient exercise activity during recent years as a basis from which to estimate future exercise patterns. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts.

 

Forfeitures are required to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

 

The following table summarizes the Company’s stock option activity for the years ended December 31, 2023, and 2022:

 

                   

Weighted

         
                   

Average

         
           

Weighted

   

Remaining

   

Aggregate

 
           

Average

   

Contractual

   

Intrinsic

 
   

Number of

   

Exercise

   

Life

   

Value

 
   

Options

   

Price

   

(in Years)

   

(in thousands)

 

Outstanding - January 1, 2023

    33,063     $ 9.04       6.8     $ -  

Granted

    -       -                  

Exercised

    -       -                  

Forfeited

    -       -                  

Outstanding - December 31, 2023

    33,063     $ 9.04       5.7     $ -  
                                 

Exercisable at December 31, 2023

    28,063     $ 9.91       5.5     $ -  

 

                   

Weighted

         
                   

Average

         
           

Weighted

   

Remaining

   

Aggregate

 
           

Average

   

Contractual

   

Intrinsic

 
   

Number of

   

Exercise

   

Life

   

Value

 
   

Options

   

Price

   

(in Years)

   

(in thousands)

 

Outstanding - January 1, 2022

    33,063     $ 9.04       7.8     $ 10.80  

Granted

    -       -                  

Exercised

    -       -                  

Forfeited

    -       -                  

Outstanding - December 31, 2022

    33,063     $ 9.04       6.8     $ -  
                                 

Exercisable at December 31, 2022

    23,063     $ 11.14       6.0     $ -  

 

There were no stock options granted in fiscal 2023 or 2022.

 

The Company recorded non-cash stock-based compensation expense of approximately $10,850 and $10,850 as a component of general and administrative expenses in the accompanying consolidated statements of operations for the years ended December 31, 2023, and 2022, pertaining to stock options awards.

 

Total unrecognized stock-based compensation expense related to unvested stock options at December 31, 2023 was approximately $5,000 and is expected to be recognized through the second quarter of 2024.

 

Warrants

 

As of December 31, 2023, and 2022, there were no warrants outstanding and exercisable.

 

Restricted Stock

 

A summary of restricted stock activity for the years ended December 31, 2023, and 2022 is as follows:

 

   

Number of

 
   

Shares

 

Outstanding - January 1, 2022

    79,763  

Granted

    170,937  

Forfeited

    (13,823 )

Vested

    (167,763 )

Outstanding - December 31, 2022

    69,114  

Granted

    117,334  

Forfeited

    (13,823 )

Vested

    (55,291 )

Outstanding - December 31, 2023

    117,334  

 

During the year ended December 31, 2023 the Company granted 30,490 restricted stock units (“RSUs”) to non-employee directors as partial compensation for their service as a director. The aggregate grant date fair value of the combined awards amounted to approximately $125,000. The RSU award to the Board member fully vests on the one-year anniversary after the date of grant. The Company also granted 86,180 RSUs to certain officers and managers with immediate vesting. The aggregate grant date fair value of the combined awards amounted to approximately $193,099.

 

During the year ended December 31, 2022 the Company granted 69,114 restricted stock units (“RSUs”) to non-employee directors as partial compensation for their service as a director. The aggregate grant date fair value of the combined awards amounted to approximately $125,000. The RSU award to the Board member fully vests on the one-year anniversary after the date of grant. The Company also granted 88,000 RSUs to certain officers and managers with immediate vesting. The aggregate grant date fair value of the combined awards amounted to approximately $284,156.

 

The Company recorded non-cash stock-based compensation expense of approximately $300,000 and $481,000 as a component of general and administrative expenses in the accompanying consolidated statements of operations for the years ended December 31, 2023, and 2022, respectively, pertaining to restricted stock awards.

 

Total unrecognized stock-based compensation expense related to unvested restricted stock at December 31, 2023 was approximately $364,000 and is expected to be recognized through the third quarter of 2025.